ChemoMetec A/S

CPSE:CHEMM Stock Report

Market Cap: DKK 7.8b

ChemoMetec Valuation

Is CHEMM undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CHEMM when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CHEMM (DKK436.8) is trading above our estimate of fair value (DKK330.55)

Significantly Below Fair Value: CHEMM is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CHEMM?

Key metric: As CHEMM is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for CHEMM. This is calculated by dividing CHEMM's market cap by their current earnings.
What is CHEMM's PE Ratio?
PE Ratio57.2x
EarningsDKK 136.28m
Market CapDKK 7.79b

Price to Earnings Ratio vs Peers

How does CHEMM's PE Ratio compare to its peers?

The above table shows the PE ratio for CHEMM vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average26x
ALK B ALK-Abelló
43.5x21.5%DKK 34.9b
BAVA Bavarian Nordic
13x5.3%DKK 13.3b
HLUN B H. Lundbeck
16.1x8.6%DKK 42.7b
AKUMS Akums Drugs and Pharmaceuticals
31.3xn/a₹87.0b
CHEMM ChemoMetec
55.8x17.2%DKK 7.8b

Price-To-Earnings vs Peers: CHEMM is expensive based on its Price-To-Earnings Ratio (55.8x) compared to the peer average (26x).

Price to Earnings Ratio vs Industry

How does CHEMM's PE Ratio compare vs other companies in the European Life Sciences Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
CHEMM 57.2xIndustry Avg. 37.1xNo. of Companies3PE020406080100+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: CHEMM is expensive based on its Price-To-Earnings Ratio (55.8x) compared to the European Life Sciences industry average (37.1x).

Price to Earnings Ratio vs Fair Ratio

What is CHEMM's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CHEMM PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio57.2x
Fair PE Ratio24.8x

Price-To-Earnings vs Fair Ratio: CHEMM is expensive based on its Price-To-Earnings Ratio (55.8x) compared to the estimated Fair Price-To-Earnings Ratio (24.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CHEMM forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentDKK 447.80
DKK 545.00
+21.7%
0.9%DKK 550.00DKK 540.00n/a2
Nov ’25DKK 408.00
DKK 438.33
+7.4%
16.2%DKK 505.00DKK 340.00n/a3
Oct ’25DKK 397.60
DKK 436.67
+9.8%
16.8%DKK 505.00DKK 335.00n/a3
Sep ’25DKK 374.60
DKK 462.50
+23.5%
2.7%DKK 475.00DKK 450.00n/a2
Aug ’25DKK 377.40
DKK 437.50
+15.9%
8.6%DKK 475.00DKK 400.00n/a2
Jul ’25DKK 301.40
DKK 437.50
+45.2%
8.6%DKK 475.00DKK 400.00n/a2
Jun ’25DKK 363.20
DKK 437.50
+20.5%
8.6%DKK 475.00DKK 400.00n/a2
May ’25DKK 294.80
DKK 462.50
+56.9%
13.5%DKK 525.00DKK 400.00n/a2
Apr ’25DKK 423.80
DKK 451.67
+6.6%
19.2%DKK 525.00DKK 330.00n/a3
Mar ’25DKK 507.00
DKK 451.67
-10.9%
19.2%DKK 525.00DKK 330.00n/a3
Feb ’25DKK 363.60
DKK 448.33
+23.3%
20.4%DKK 525.00DKK 320.00n/a3

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.

Discover undervalued companies